Being part of a double digit growth industry, reasons major cutbacks combined with a high degree of maturity will have significant effect on current business models. Recent strategies proclaimed fleeting stakes to capture market share within emerging markets to compensate losses in established markets.
However, strong cuts in public spending are now observable not only in the US but also in major EU markets. Management of Medical Devices Companied are faced with multiple complex set of questions focusing on innovation and engineering excellence, Regulatory excellence, Market access, Pricing and Outcome related Reimbursement Strategies, Consolidation, but also facing new and fierce competition from agile ITC companies.
To be able to address these challenges with the right management attention and response, the Deloitte Medical Devices Sector team has outstanding thought-leadership, board cross-functional capabilities and understanding of your need to succeed.